Noonan syndrome‐like phenotype associated with an ERF frameshift variant
American Journal of Medical Genetics Part A · 2024
DOI: 10.1002/ajmg.a.63652 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Yasuhiro Hirano und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Hiratsuka City Hospital, Hiratsuka, Kanagawa, Japan. Hauptthemen laut MEDLINE: Frameshift Mutation, Noonan Syndrome, Repressor Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: MHLW Health Labour Sciences Research, The Initiative on Rare and Undiagnosed Diseases, Japan Agency for Medical Research and Development, Grants-in-Aid for the Practical Research Project for Rare/Intractable Diseases, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Noonan syndrome is a so‐called “RASopathy,” that is characterized by short stature, distinctive facial features, congenital heart defects, and developmental delay. Of individuals with a clinical diagnosis of Noonan syndrome, 80%–90% have pathogenic variants in the known genes implicated in the disorder, but the molecular mechanism is unknown in the remaining cases. Heterozygous pathogenic variants of ETS2 repressor factor ( ERF ), which functions as a repressor in the RAS/MAPK signaling pathway, cause syndromic craniosynostosis. Here, we report an ERF frameshift variant cosegregating with a Noonan syndrome‐like phenotype in a family. The proband was a 3‐year‐old female who presented with dysmorphic facial features, including proptosis, hypertelorism, slightly down slanted palpebral fissures, low‐set posteriorly rotated ears, depressed nasal bridge, short stature, and developmental delay. Exome sequencing of the proband identified a heterozygous ERF variant [NM_006494.4: c.185del p.(Glu62Glyfs*15)]. Her mother and sister showed a similar phenotype and had the same heterozygous ERF variant. A large proportion of the previously reported patients with syndromic craniosynostosis and pathogenic ERF variants also showed characteristic features that overlap with those of Noonan syndrome. The present finding supports an association between heterozygous ERF variants and a Noonan syndrome‐like phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Hiratsuka City Hospital, Hiratsuka, Kanagawa, Japan.
- Department of Endocrinology and Metabolism, Kanagawa Children's Medical Center, Yokohama, Japan.
- Division of Medical Genetics, Kanagawa Children's Medical Center, Yokohama, Japan.
- Clinical Research Institute, Kanagawa Children's Medical Center, Yokohama, Japan.
ORCID-Profile: Yasuhiro Hirano, Yukiko Kuroda, Kenji Kurosawa
Förderung
- MHLW Health Labour Sciences Research
- The Initiative on Rare and Undiagnosed Diseases, Japan Agency for Medical Research and Development
- Grants-in-Aid for the Practical Research Project for Rare/Intractable Diseases, Japan Agency for Medical Research and Development
Zitieren
APA
Hirano, Y., Kuroda, Y., Enomoto, Y., Naruto, T., Muroya, K., & Kurosawa, K. (2024). Noonan syndrome‐like phenotype associated with an ERF frameshift variant. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63652
Vancouver
Hirano Y, Kuroda Y, Enomoto Y, Naruto T, Muroya K, Kurosawa K. Noonan syndrome‐like phenotype associated with an ERF frameshift variant. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63652
BibTeX
@article{Hirano2024,
author = {Hirano, Yasuhiro and Kuroda, Yukiko and Enomoto, Yumi and Naruto, Takuya and Muroya, Koji and Kurosawa, Kenji},
title = {Noonan syndrome‐like phenotype associated with an ERF frameshift variant},
journal = {American Journal of Medical Genetics Part A},
year = {2024},
doi = {10.1002/ajmg.a.63652}
}
EUVIMED